Phosphaturic mesenchymal tumour, mixed connective tissue type

From Libre Pathology
Jump to navigation Jump to search
Phosphaturic mesenchymal tumour, mixed connective tissue type
Diagnosis in short

Phosphaturic mesenchymal tumour, mixed connective tissue type. H&E stain.

LM spindle cells without atypia
LM DDx osteosarcoma, neurofibroma, other soft tissue lesions
IHC vimentin +ve, pankeratin -ve, S-100 -ve
Site soft tissue, bone

Prevalence very rare
Blood work low serum phosphate
Clin. DDx autosomal dominant hypophosphatemic rickets

Phosphaturic mesenchymal tumour, mixed connective tissue type, abbreviated PMTMCT, is a rare tumour.

General

Clinical DDx:

  • Autosomal dominant hypophosphatemic rickets.[3]

Gross

  • Soft tissue or bone.[4]
  • Often small - thus hard to identify.[5]

Microscopic

Features:[2][3]

  • Spindle cells without atypia and moderate lightly eosinophilic cytoplasm without distinctive cell borders.
  • Eosinophilic matrix - described as "gungy" (shabby).[6]
  • HPC-like vessels.
  • Osteoclast-type giant cells.
  • +/-Hemorrhage.
  • +/-Calcifications.


DDx:[6]

Images

www:

IHC

Features:[3]

  • FGF-23 +ve -- key immunostain (17 +ve/21 cases).[6]
  • Vimentin +ve.
  • Pankeratin -ve.
  • S-100 -ve.
  • CD34 -ve.

Others:[7]

  • CD68 +ve.(???)
  • Desmin -ve.
  • Actin -ve/+ve (3 +ve/21 cases).[6]

Sign out

LEFT CALF, BIOPSY:
- SPINDLE CELL LESION WITHOUT SIGNIFICANT NUCLEAR ATYPIA AND SHABBY HYALINE
  MATERIAL WITH CALCIFICATIONS, SEE COMMENT.

COMMENT:
The tumour stains as follows:
POSITIVE: vimentin, CD68 (focal).
NEGATIVE: pankeratin, S-100, CD34.
PROLIFERATION (Ki-67): 3% of lesional cells.

This probably represents a recurrence of the "phosphaturic mesenchymal tumour, mixed
connective tissue type". 

The case was compared to the previous pathology. Clinical correlation is recommended.

References

  1. Papierska, L.; Ćwikła, JB.; Misiorowski, W.; Rabijewski, M.; Sikora, K.; Wanyura, H. (2013). "Unusual case of phosphaturic mesenchymal tumor.". Pol Arch Med Wewn 123 (5): 255-6. PMID 23722193.
  2. 2.0 2.1 William, J.; Laskin, W.; Nayar, R.; De Frias, D. (Aug 2012). "Diagnosis of phosphaturic mesenchymal tumor (mixed connective tissue type) by cytopathology.". Diagn Cytopathol 40 Suppl 2: E109-13. doi:10.1002/dc.21647. PMID 22927293.
  3. 3.0 3.1 3.2 3.3 Woo, VL.; Landesberg, R.; Imel, EA.; Singer, SR.; Folpe, AL.; Econs, MJ.; Kim, T.; Harik, LR. et al. (Dec 2009). "Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.". Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 (6): 925-32. doi:10.1016/j.tripleo.2009.07.005. PMC 2783479. PMID 19828339. //www.ncbi.nlm.nih.gov/pmc/articles/PMC2783479/.
  4. Jiang, Y.; Xia, WB.; Xing, XP.; Silva, BC.; Li, M.; Wang, O.; Zhang, HB.; Li, F. et al. (Sep 2012). "Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.". J Bone Miner Res 27 (9): 1967-75. doi:10.1002/jbmr.1642. PMID 22532501.
  5. Ledford, CK.; Zelenski, NA.; Cardona, DM.; Brigman, BE.; Eward, WC. (Jul 2013). "The Phosphaturic Mesenchymal Tumor: Why is Definitive Diagnosis and Curative Surgery Often Delayed?". Clin Orthop Relat Res. doi:10.1007/s11999-013-3178-1. PMID 23868423.
  6. 6.0 6.1 6.2 6.3 Folpe AL, Fanburg-Smith JC, Billings SD, et al. (January 2004). "Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature". Am. J. Surg. Pathol. 28 (1): 1–30. PMID 14707860.
  7. 7.0 7.1 Hu FK, Yuan F, Jiang CY, et al. (November 2011). "Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature". Chin J Cancer 30 (11): 794–804. doi:10.5732/cjc.011.10013. PMC 4013303. PMID 22035861. //www.ncbi.nlm.nih.gov/pmc/articles/PMC4013303/.